|
1
|
Pavlidis NA: Coexistence of pregnancy and
malignancy. Oncologist. 7:279–287. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lishner M, Avivi I, Apperley JF, Dierickx
D, Evens AM, Fumagalli M, Nulman I, Oduncu FS, Peccatori FA,
Robinson S, et al: Hematologic malignancies in pregnancy:
Management guidelines from an international consensus meeting. J
Clin Oncol. 34:501–508. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pereg D, Koren G and Lishner M: The
treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy.
Haematologica. 92:1230–1237. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fenig E, Mishaeli M, Kalish Y and Lishner
M: Pregnancy and radiation. Cancer Treat Rev. 27:1–7. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shaw P, Duncan A, Vouyouka A and Ozsvath
K: Radiation exposure and pregnancy. J Vasc Surg. 53 1
Suppl:28S–34S. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chandra V, Dorsey C, Reed AB, Shaw P,
Banghart D and Zhou W: Monitoring of fetal radiation exposure
during pregnancy. J Vasc Surg. 58:710–714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Groen RS, Bae JY and Lim KJ: Fear of the
unknown: Ionizing radiation exposure during pregnancy. Am J Obstet
Gynecol. 206:456–462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawabata I, Takahashi Y, Iwagaki S and
Tamaya T: MRI during pregnancy. J Perinat Med. 31:449–458. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bulas D and Egloff A: Benefits and risks
of MRI in pregnancy. Semin Perinatol. 37:301–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anderson GD: Pregnancy-induced changes in
pharmacokinetics: A mechanistic-based approach. Clin Pharmacokinet.
44:989–1008. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feghali M, Venkataramanan R and Caritis S:
Pharmacokinetics of drugs in pregnancy. Semin Perinatol.
39:512–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Autio K, Rassnick KM and Bedford-Guaus SJ:
Chemotherapy during pregnancy: A review of the literature. Vet Comp
Oncol. 5:61–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Van Calsteren K: Chemotherapy during
pregnancy: Pharmacokinetics and impact on foetal neurological
development. Facts Views Vis Obgyn. 2:278–286. 2010.PubMed/NCBI
|
|
14
|
Abdel-Hady el S, Hemida RA, Gamal A,
El-Zafarany M, Toson E and El-Bayoumi MA: Cancer during pregnancy:
Perinatal outcome after in utero exposure to chemotherapy. Arch
Gynecol Obstet. 286:283–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vandenbroucke T and Amant F: Development
of children born to mothers with cancer during pregnancy: Comparing
in utero chemotherapy-exposed children with nonexposed controls. Am
J Obstet Gynecol. 212:830–831. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cardonick E and Iacobucci A: Use of
chemotherapy during human pregnancy. Lancet Oncol. 5:283–291. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abramson JS, Hellmann M, Barnes JA,
Hammerman P, Toomey C, Takvorian T, Muzikansky A and Hochberg EP:
Intravenous methotrexate as central nervous system (CNS)
prophylaxis is associated with a low risk of CNS recurrence in
high-risk patients with diffuse large B-cell lymphoma. Cancer.
116:4283–4290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Germann N, Goffinet F and Goldwasser F:
Anthracyclines during pregnancy: Embryo-fetal outcome in 160
patients. Ann Oncol. 15:146–150. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bookstaver PB, Bland CM, Griffin B, Stover
KR, Eiland LS and McLaughlin M: A review of antibiotic use in
pregnancy. Pharmacotherapy. 35:1052–1062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boxer LA, Bolyard AA, Kelley ML, Marrero
TM, Phan L, Bond JM, Newburger PE and Dale DC: Use of granulocyte
colony-stimulating factor during pregnancy in women with chronic
neutropenia. Obstet Gynecol. 125:197–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Larrimer MB, Dajani NK, Siegel ER, Eswaran
H, Newport DJ and Stowe ZN: Antiemetic medications in pregnancy: A
prospective investigation of obstetric and neurobehavioral
outcomes. Am J Obstet Gynecol. 210:e1–e7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goland S and Elkayam U: Anticoagulation in
pregnancy. Cardiol Clin. 30:395–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gibbs RS, Romero R, Hillier SL, Eschenbach
DA and Sweet RL: A review of premature birth and subclinical
infection. Am J Obstet Gynecol. 166:1515–1528. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boleti E and Mead GM: ABVD for Hodgkin's
lymphoma: Full-dose chemotherapy without dose reductions or growth
factors. Ann Oncol. 18:376–380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Avilés A, Neri N and Nambo MJ: Long-term
evaluation of cardiac function in children who received
anthracyclines during pregnancy. Ann Oncol. 17:286–288. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ansell SM: Hodgkin lymphoma: 2014 update
on diagnosis, risk-stratification, and management. Am J Hematol.
89:771–779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weibull CE, Eloranta S, Smedby KE,
Björkholm M, Kristinsson SY, Johansson AL, Dickman PW and Glimelius
I: Pregnancy and the risk of relapse in patients diagnosed with
Hodgkin lymphoma. J Clin Oncol. 34:337–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chakravarty EF, Murray ER, Kelman A and
Farmer P: Pregnancy outcomes after maternal exposure to rituximab.
Blood. 117:1499–1506. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Klink DT, van Elburg RM, Schreurs MW and
van Well GT: Rituximab administration in third trimester of
pregnancy suppresses neonatal B-cell development. Clin Dev Immunol.
2008:2713632008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hyoun SC, Običan SG and Scialli AR:
Teratogen update: Methotrexate. Birth Defects Res A Clin Mol
Teratol. 94:187–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lloyd M, McElhatton P, Carr M, Hall G and
Hughes R: Methotrexate in pregnancy. Rheumatology (Oxford).
44:6972005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Döhner H, Estey E, Grimwade D, Amadori S,
Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA,
et al: Diagnosis and management of AML in adults: 2017 ELN
recommendations from an international expert panel. Blood.
129:424–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ganzel C, Becker J, Mintz PD, Lazarus HM
and Rowe JM: Hyperleukocytosis, leukostasis and leukapheresis:
Practice management. Blood Rev. 26:117–122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang A and Patel S: Treatment of acute
myeloid leukemia during pregnancy. Ann Pharmacother. 49:48–68.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McGregor AK and Das-Gupta E: Acute myeloid
leukaemia in pregnancy. Br J Haematol. 170:441–442. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Milojkovic D and Apperley JF: How I treat
leukemia during pregnancy. Blood. 123:974–984. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maru Y: Molecular biology of chronic
myeloid leukemia. Cancer Sci. 103:1601–1610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bazarbashi MS, Smith MR, Karanes C,
Zielinski I and Bishop CR: Successful management of Ph chromosome
chronic myelogenous leukemia with leukapheresis during pregnancy.
Am J Hematol. 38:235–237. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baccarani M, Deininger MW, Rosti G,
Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes
JE, Guilhot F, et al: European LeukemiaNet recommendations for the
management of chronic myeloid leukemia: 2013. Blood. 122:872–884.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hochhaus A, Larson RA, Guilhot F, Radich
JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F,
Fujihara S, et al: Long-term outcomes of imatinib treatment for
chronic myeloid leukemia. N Engl J Med. 376:917–927. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Steegmann JL, Baccarani M, Breccia M,
Casado LF, García-Gutiérrez V, Hochhaus A, Kim DW, Kim TD, Khoury
HJ, Le Coutre P, et al: European LeukemiaNet recommendations for
the management and avoidance of adverse events of treatment in
chronic myeloid leukaemia. Leukemia. 30:1648–1671. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nurmio M, Kallio J, Toppari J and
Jahnukainen K: Adult reproductive functions after early postnatal
inhibition by imatinib of the two receptor tyrosine kinases, c-kit
and PDGFR, in the rat testis. Reprod Toxicol. 25:442–446. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Apperley J: Issues of imatinib and
pregnancy outcome. J Natl Compr Canc Netw. 7:1050–1058. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ault P, Kantarjian H, O'Brien S, Faderl S,
Beran M, Rios MB, Koller C, Giles F, Keating M, Talpaz M and Cortes
J: Pregnancy among patients with chronic myeloid leukemia treated
with imatinib. J Clin Oncol. 24:1204–1208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pye SM, Cortes J, Ault P, Hatfield A,
Kantarjian H, Pilot R, Rosti G and Apperley JF: The effects of
imatinib on pregnancy outcome. Blood. 111:5505–5508. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Barkoulas T and Hall PD: Experience with
dasatinib and nilotinib use in pregnancy. J Oncol Pharm Pract.
24:121–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cortes JE, Abruzzese E, Chelysheva E, Guha
M, Wallis N and Apperley JF: The impact of dasatinib on pregnancy
outcomes. Am J Hematol. 90:1111–1115. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hermel DJ, Chiu V, Hermel MH, Tulpule A
and Akhtari M: Cardiac birth defects in a twin infant born to a
woman with chronic myeloid leukemia on dasatinib. J Oncol Pharm
Pract. Jan 1–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Abruzzese E, Trawinska MM, de Fabritiis P
and Baccarani M: Management of pregnant chronic myeloid leukemia
patients. Expert Rev Hematol. 9:781–791. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Law AD, Dong Hwan, Kim D and Lipton JH:
Pregnancy: Part of life in chronic myelogenous leukemia. Leuk
Lymphoma. 58:280–287. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Etienne G, Guilhot J, Rea D, Rigal-Huguet
F, Nicolini F, Charbonnier A, Guerci-Bresler A, Legros L, Varet B,
Gardembas M, et al: Long-term follow-up of the French Stop Imatinib
(STIM1) study in patients with chronic myeloid leukemia. J Clin
Oncol. 35:298–305. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hochhaus A, Masszi T, Giles FJ, Radich JP,
Ross DM, Casares Gómez MT, Hellmann A, Stentoft J, Conneally E,
García-Gutiérrez V, et al: Treatment-free remission following
frontline nilotinib in patients with chronic myeloid leukemia in
chronic phase: Results from the ENESTfreedom study. Leukemia.
31:1525–1531. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ross DM, Branford S, Seymour JF, Schwarer
AP, Arthur C, Yeung DT, Dang P, Goyne JM, Slader C, Filshie RJ, et
al: Safety and efficacy of imatinib cessation for CML patients with
stable undetectable minimal residual disease: Results from the
TWISTER study. Blood. 122:515–522. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pallera A, Altman JK, Berman E, Abboud CN,
Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hagelstrom RT, Hobbs
G, et al: NCCN guidelines insights: Chronic myeloid leukemia,
version 1.2017. J Natl Compr Canc Netw. 14:1505–1512. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Celiloglu M, Altunyurt S and Undar B:
Hydroxyurea treatment for chronic myeloid leukemia during
pregnancy. Acta Obstet Gynecol Scand. 79:803–804. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fiorani C, Tonelli S, Casolari B and
Sacchi S: The role of interferon-alpha in the treatment of
myeloproliferative disorders. Curr Pharm Des. 5:987–1013.
1999.PubMed/NCBI
|
|
57
|
Lipton JH, Derzko CM and Curtis J:
Alpha-interferon and pregnancy in a patient with CML. Hematol
Oncol. 14:119–122. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wright CA and Tefferi A: A single
institutional experience with 43 pregnancies in essential
thrombocythemia. Eur J Haematol. 66:152–159. 2001. View Article : Google Scholar : PubMed/NCBI
|
